Literature DB >> 19295495

Endotoxin and interferon-gamma inhibit translation in skeletal muscle cells by stimulating nitric oxide synthase activity.

Robert A Frost1, Gerald J Nystrom, Charles H Lang.   

Abstract

The purpose of the present study was to test the hypothesis that endogenous NO negatively affects translation in skeletal muscle cells after exposure to a combination of endotoxin (LPS) and interferon-gamma (IFN-gamma). Individually, LPS and IFN-gamma did not alter protein synthesis, but in combination, they inhibited protein synthesis by 80% in C2C12 myotubes. The combination of LPS and IFN-gamma dramatically downregulated the autophosphorylation of the mammalian target of rapamycin and its substrates S6K1 and 4EBP-1. The phosphorylation of ribosomal protein S6 was decreased, whereas phosphorylation of elongation factor 2 and raptor was enhanced, consistent with defects in both translation initiation and elongation. Reduced S6 phosphorylation occurred 8 to 18 h after LPS/IFN-gamma and coincided with a prolonged upregulation of NOS2 messenger RNA and protein. NOS2 protein expression and the LPS/IFN-gamma-induced fall in phosphorylated S6 were prevented by the proteasome inhibitor MG-132. The general NOS inhibitor, L-NAME, and the specific NOS2 inhibitor, 1400W, also prevented the LPS/IFN-gamma-induced decrease in protein synthesis and restored translational signaling. LPS/IFN-gamma downregulated the phosphorylation of multiple Akt substrates, including the proline-rich Akt substrate 40, while enhancing the phosphorylation of raptor on a 5'-AMP-activated kinase (AMPK)-regulated site. The negative effects of LPS/IFN-gamma were blunted by the AMPK inhibitor compound C. The data suggest that, in combination, LPS and IFN-gamma induce a prolonged expression of NOS2 and excessive production of NO that reciprocally alter Akt and AMPK activity and consequently downregulate translation via reduced mammalian target of rapamycin signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295495      PMCID: PMC3323117          DOI: 10.1097/SHK.0b013e3181a034d2

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  39 in total

Review 1.  The origins of cachexia in acute and chronic inflammatory diseases.

Authors:  Matthew J Delano; Lyle L Moldawer
Journal:  Nutr Clin Pract       Date:  2006-02       Impact factor: 3.080

2.  Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control.

Authors:  Mickaël Ohanna; Andrew K Sobering; Thomas Lapointe; Lazaro Lorenzo; Christophe Praud; Emmanuel Petroulakis; Nahum Sonenberg; Paul A Kelly; Athanassia Sotiropoulos; Mario Pende
Journal:  Nat Cell Biol       Date:  2005-02-20       Impact factor: 28.824

3.  Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes.

Authors:  Robert A Frost; Gerald J Nystrom; Charles H Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-10-27       Impact factor: 3.619

4.  Proteomic identification of S-nitrosylated proteins in Arabidopsis.

Authors:  Christian Lindermayr; Gerhard Saalbach; Jörg Durner
Journal:  Plant Physiol       Date:  2005-02-25       Impact factor: 8.340

5.  Nitric oxide induces apoptosis in mouse C2C12 myoblast cells.

Authors:  Myoung-Hwa Lee; Mi-Hyeon Jang; Eun-Kyung Kim; Sang-Wan Han; Seong-Yeon Cho; Chang-Ju Kim
Journal:  J Pharmacol Sci       Date:  2005-03-17       Impact factor: 3.337

6.  S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance.

Authors:  Takashi Yasukawa; Eriko Tokunaga; Hidetaka Ota; Hiroki Sugita; J A Jeevendra Martyn; Masao Kaneki
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

Review 7.  Novel aspects on the regulation of muscle wasting in sepsis.

Authors:  Per-Olof Hasselgren; Michael J Menconi; Moin U Fareed; Hongmei Yang; Wei Wei; Amy Evenson
Journal:  Int J Biochem Cell Biol       Date:  2005-03-13       Impact factor: 5.085

8.  NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release.

Authors:  Sergio Di Marco; Rachid Mazroui; Patrice Dallaire; Sridar Chittur; Scott A Tenenbaum; Danuta Radzioch; Andre Marette; Imed-Eddine Gallouzi
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

9.  Identification of an inducible nitric oxide synthase in diaphragm mitochondria from septic mice: its relation with mitochondrial dysfunction and prevention by melatonin.

Authors:  Luis C López; Germaine Escames; Víctor Tapias; Pilar Utrilla; Josefa León; Darío Acuña-Castroviejo
Journal:  Int J Biochem Cell Biol       Date:  2005-09-30       Impact factor: 5.085

10.  Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha.

Authors:  Charles H Lang; Robert A Frost
Journal:  Metabolism       Date:  2007-01       Impact factor: 8.694

View more
  25 in total

1.  Inhibition of glycogen synthase kinase 3[beta] activity with lithium in vitro attenuates sepsis-induced changes in muscle protein turnover.

Authors:  Stephen Bertsch; Charles H Lang; Thomas C Vary
Journal:  Shock       Date:  2011-03       Impact factor: 3.454

2.  Insulin stimulates human skeletal muscle protein synthesis via an indirect mechanism involving endothelial-dependent vasodilation and mammalian target of rapamycin complex 1 signaling.

Authors:  Kyle L Timmerman; Jessica L Lee; Hans C Dreyer; Shaheen Dhanani; Erin L Glynn; Christopher S Fry; Micah J Drummond; Melinda Sheffield-Moore; Blake B Rasmussen; Elena Volpi
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

Review 3.  mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong?

Authors:  Robert A Frost; Charles H Lang
Journal:  Physiology (Bethesda)       Date:  2011-04

4.  Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine.

Authors:  Charles H Lang; Robert A Frost; Sarah K Bronson; Christopher J Lynch; Thomas C Vary
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-13       Impact factor: 4.310

5.  Sepsis-induced alterations in protein-protein interactions within mTOR complex 1 and the modulating effect of leucine on muscle protein synthesis.

Authors:  Abid A Kazi; Anne M Pruznak; Robert A Frost; Charles H Lang
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

6.  GSK3β-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury.

Authors:  Dae Won Park; Shaoning Jiang; Yanping Liu; Gene P Siegal; Ken Inoki; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-19       Impact factor: 5.464

7.  Salutary effect of aurintricarboxylic acid on endotoxin- and sepsis-induced changes in muscle protein synthesis and inflammation.

Authors:  Lacee J Laufenberg; Abid A Kazi; Charles H Lang
Journal:  Shock       Date:  2014-05       Impact factor: 3.454

8.  Leucine supplementation stimulates protein synthesis and reduces degradation signal activation in muscle of newborn pigs during acute endotoxemia.

Authors:  Adriana D Hernandez-García; Daniel A Columbus; Rodrigo Manjarín; Hanh V Nguyen; Agus Suryawan; Renán A Orellana; Teresa A Davis
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-09-13       Impact factor: 4.310

9.  Aging accentuates alcohol-induced decrease in protein synthesis in gastrocnemius.

Authors:  Donna H Korzick; Daniel R Sharda; Anne M Pruznak; Charles H Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-27       Impact factor: 3.619

10.  Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults.

Authors:  John R Stehle; Xiaoyan Leng; Dalane W Kitzman; Barbara J Nicklas; Stephen B Kritchevsky; Kevin P High
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-07       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.